Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
24 November, 2017 03:55 IST
Strides Shasun gets USFDA nod for Potassium Citrate ER tablets
Source: IRIS | 12 Sep, 2017, 10.15AM
Comments  |  Post Comment

Strides Shasun has received approval from the United States Food & Drug Administration (USFDA) for Potassium Citrate Extended-Release Tablets USP, 5 mEq, 10 mEq, and 15 mEq.

According to IMS data, the US market for Potassium Citrate is approximately USD 110 million.

The company will be the second generic player to commercialize the product. The product, which is the first approval for an Extended Release tablet for the company, will be launched immediately.

Potassium Citrate, a urinary alkalinizing agent, is used for preventing certain types of kidney stones. It works by neutralizing some of the acid in the urine, which helps reduce the formation of crystals. 

Shares of the company gained Rs 28.7, or 3.05%, to trade at Rs 970.00. The total volume of shares traded was 46,320 at the BSE (9.58 a.m., Tuesday).



Strides Shasun Limited   (Q,N,C,F)*

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Sector
Thomas Cook to sell 5.42% stake in Quess Corp via OFS - 23-Nov-2017 10:28
Tata Tele subscribers commence transitioning to Airtel network - 23-Nov-2017 10:13
Glenmark Pharma gets nod for generic Loestrin Fe 1/20 tablets - 22-Nov-2017 11:27
Strides Shasun's arm receives USFDA approval for Acetazolamide tablets - 22-Nov-2017 10:41
Ramco Systems inks multi-million dollar order with LBC Express - 22-Nov-2017 10:08
NCC in consortium with BGR Infra bags Talaipalli coal block project - 22-Nov-2017 09:56
L&T Tech Services features in leader category for IoT services - 22-Nov-2017 09:52
Zydus' oral anemia developmental candidate; ZYAN1 named as Desidustat by WHO - 21-Nov-2017 12:51
Dr. Reddy's receives EIR from USFDA for Vishakhapatnam facility - 21-Nov-2017 12:46
Artefact Projects bags various orders worth Rs 292.6 mn - 21-Nov-2017 12:34
Yes Bank raises USD 400 mn via syndicated loan transactions in Taiwan, Japan - 21-Nov-2017 12:24
more...
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer